Cochlear Limited ( (AU:COH) ) just unveiled an announcement.
Cochlear Limited announced that despite the new 10% tariff on Australian exports to the US, their hearing implants will continue to be imported duty-free under a specific chapter of the Harmonized Tariff Schedule. The company remains committed to monitoring global trade developments to ensure they can continue to deliver and support their hearing solutions worldwide.
More about Cochlear Limited
Cochlear Limited is a company in the medical device industry, specializing in implantable hearing solutions. Their primary products include hearing implants, and they focus on providing these solutions to individuals with hearing loss globally.
YTD Price Performance: -11.71%
Average Trading Volume: 54
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.26B
See more insights into COH stock on TipRanks’ Stock Analysis page.